NCT01425671Completed
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
Source: ClinicalTrials.gov · Last updated 26 Apr 2024
Brief summary (registry, in English)
The principle aim of the project is to analyze brain electrical activity and genetic information that will help identify the nature and cause of the disease schizophrenia. This effort should lay the groundwork for future treatment in schizophrenic patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 800 (estimated)
- First submitted
- 28 Aug 2011
- Start date
- 30 Nov 2010
- Primary completion date
- 31 Aug 2023
- Lead sponsor
- University of Maryland, Baltimore
- Diseases
- Schizophrenia
- NCT number
- NCT01425671
What you commit to
- Study type: Observational
- Planned participants: 800
- From 30 Nov 2010 to the primary completion date, 31 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Significant alcohol or drug use (substance dependence within 6 months or substance abuse within 1 month) other than nicotine or marijuana dependence.
- Can not refrain from using alcohol and/or marijuana 24 hours or more\& cigarette smoking half and hour or more prior to experiments.
Other illness
- Any major medical illness that may affect normal brain functioning. Examples of these conditions include, but not limited to, stroke, repeated seizure, history of significant head trauma, CNS infection or tumor, an other significant brain neurological conditions.
Other
- Inability to sign informed consent/assent
- Woman who is pregnant (child bearing potential but not on contraceptive and missing menstrual period; or by self-report; or by positive pregnancy test).
Who the study is looking for
- Male and Female between ages 14-62 (clinical assessment and blood draw only above 62)
- Ability to give written assent (subjects who are below the age of 18)
- Ability to give written informed consent (age 18 or above)
- Sufficient understanding of the study and risks (ESC score 10 or above)
- Subjects above age 62 will not participate in brain electrical activity measurements although they may still participate in clinical assessments and blood draw.
Age in the registry: 14 years to 62 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maryland Psychiatric Research Center Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.